{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:28:15Z","timestamp":1773797295507,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":599,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo (FAPESP)"},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.pnpbp.2011.07.017","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T03:46:00Z","timestamp":1312688760000},"page":"1884-1890","source":"Crossref","is-referenced-by-count":30,"title":["Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism"],"prefix":"10.1016","volume":"35","author":[{"given":"Andr\u00e9a L.","family":"Serti\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela May","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rog\u00e9rio A.L.","family":"Serti\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Andreotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio B.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Passos-Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner F.","family":"Gattaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pnpbp.2011.07.017_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1517\/14740338.4.1.55","article-title":"Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?","volume":"4","author":"Ananth","year":"2005","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.pnpbp.2011.07.017_bb0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-2004-815527","article-title":"Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients","volume":"37","author":"Bergemann","year":"2004","journal-title":"Pharmacopsychiatry"},{"issue":"5\u20136","key":"10.1016\/j.pnpbp.2011.07.017_bb0015","first-page":"63","article-title":"Atypical antipsychotics in the treatment of schizophrenia","volume":"133","author":"Bridler","year":"2003","journal-title":"Swiss Med Wkly"},{"issue":"4","key":"10.1016\/j.pnpbp.2011.07.017_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-2007-979318","article-title":"Acute clozapine overdose: plasma concentration and outcome","volume":"31","author":"Broich","year":"1998","journal-title":"Pharmacopsychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.pnpbp.2011.07.017_bb0025","first-page":"15S","article-title":"Metabolic issues and cardiovascular disease in patients with psychiatric disorders","volume":"118","author":"Casey","year":"2005","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.07.017_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1176\/ajp.155.1.48","article-title":"Haloperidol plasma levels and dose optimization","volume":"155","author":"Coryell","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.07.017_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2009.11.009","article-title":"The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?","volume":"34","author":"Deng","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2011.07.017_bb0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jnr.21491","article-title":"Effects of antipsychotic medication on muscarinic M1 receptor mRNA expression in the rat brain","volume":"86","author":"Han","year":"2008","journal-title":"J Neurosci Res"},{"issue":"11","key":"10.1016\/j.pnpbp.2011.07.017_bb0045","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/sj.mp.4001892","article-title":"Clozapine enhances differentiation of adipocyte progenitor cells","volume":"11","author":"Hemmrich","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2011.07.017_bb0050","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1097\/PRS.0b013e3181ef8beb","article-title":"Local anesthetics have a major impact on viability of preadipocytes and their differentiation into adipocytes","volume":"126","author":"Keck","year":"2010","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.07.017_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2005.07.038","article-title":"HGGN Study Group. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia","volume":"81","author":"Keefe","year":"2006","journal-title":"Schizophr Res"},{"issue":"5","key":"10.1016\/j.pnpbp.2011.07.017_bb0060","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2133\/dmpk.20.368","article-title":"Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus","volume":"20","author":"Matsui-Sakata","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pnpbp.2011.07.017_bb0065","first-page":"15","article-title":"Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders","volume":"4","author":"McDougle","year":"2008","journal-title":"Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2011.07.017_bb0070","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/sj.mp.4001948","article-title":"Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment","volume":"12","author":"Minet-Ringuet","year":"2007","journal-title":"Mol Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.pnpbp.2011.07.017_bb0075","first-page":"20","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2011.07.017_bb0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2217\/pgs.10.50","article-title":"Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample","volume":"11","author":"Opgen-Rhein","year":"2010","journal-title":"Pharmacogenomics"},{"issue":"11","key":"10.1016\/j.pnpbp.2011.07.017_bb0085","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/070674370905401104","article-title":"Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications","volume":"54","author":"Panagiotopoulos","year":"2009","journal-title":"Can J Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2011.07.017_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11920-008-0077-3","article-title":"Use of atypical antipsychotics for treatment-resistant major depressive disorder","volume":"10","author":"Papakostas","year":"2008","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"10.1016\/j.pnpbp.2011.07.017_bb0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/tpj.2009.67","article-title":"Weight gain related to treatment with atypical antipsychotics is due to activation of PKC-beta","volume":"10","author":"Pavan","year":"2009","journal-title":"Pharmacogenomics J"},{"issue":"7","key":"10.1016\/j.pnpbp.2011.07.017_bb0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2165\/11533110-000000000-00000","article-title":"Pharmacotherapy of bipolar disorder in children and adolescents: recent progress","volume":"24","author":"Pfeifer","year":"2010","journal-title":"CNS Drugs"},{"issue":"9323","key":"10.1016\/j.pnpbp.2011.07.017_bb0105","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/S0140-6736(02)08913-4","article-title":"Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism","volume":"359","author":"Reynolds","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pnpbp.2011.07.017_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pnpbp.2005.06.008","article-title":"At therapeutic concentrations, olanzapine does not affect basal or insulin-stimulated glucose transport in 3T3-L1 adipocytes","volume":"30","author":"Robinson","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7196","key":"10.1016\/j.pnpbp.2011.07.017_bb0115","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nature06902","article-title":"Dynamics of fat cell turnover in humans","volume":"453","author":"Spalding","year":"2008","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.pnpbp.2011.07.017_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.pnpbp.2011.07.017_bb0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.npp.1301142","article-title":"Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis","volume":"32","author":"Vestri","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.07.017_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2010.05.060","article-title":"Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state","volume":"1350","author":"Victoriano","year":"2010","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.07.017_bb0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.eurpsy.2008.09.003","article-title":"The use of ziprasidone in clinical practice: analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey","volume":"24","author":"Vogel","year":"2009","journal-title":"Eur Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2011.07.017_bb0140","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2007.05.007","article-title":"Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells","volume":"56","author":"Yang","year":"2007","journal-title":"Pharmacol Res"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2011.07.017_bb0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cca.2009.07.021","article-title":"Evidence for an effect of clozapine on the regulation of fat-cell derived factors","volume":"408","author":"Yang","year":"2009","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.pnpbp.2011.07.017_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611002478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T21:20:50Z","timestamp":1560460850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611002478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0278584611002478"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.07.017","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}